Tower Research Capital LLC (Trc) Rezolute, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Rezolute, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 4,117 shares of RZLT stock, worth $20,214. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,117Holding current value
$20,214% of portfolio
0.0%Shares
12 transactions
Others Institutions Holding RZLT
# of Institutions
62Shares Held
38.5MCall Options Held
1.6KPut Options Held
24.6K-
Federated Hermes, Inc. Pittsburgh, PA11.3MShares$55.4 Million0.13% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.8MShares$13.7 Million1.99% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.58MShares$12.7 Million0.74% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.93MShares$9.49 Million0.0% of portfolio
-
Blackstone Inc New York, NY1.74MShares$8.57 Million0.04% of portfolio
About Rezolute, Inc.
- Ticker RZLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,827,600
- Market Cap $191M
- Description
- Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultr...